The global market for pain management is expected to grow at a fast pace. Key factors influencing the growth include chronic diseases, lifestyle disorders like obesity and diabetes, muscle and nerve stimulators, rising need for pain management in cancer, and the high prevalence of musculoskeletal disorders such as arthritis, osteoarthritis, orthopedic degenerative disorders, and rheumatoid arthritis.
Some factors that drive the growth of the global pain management market are the rise in the geriatric population that is more prone to suffer from joint pain and arthritis, chronic diseases such as cancer, diabetic neuropathy, and osteoarthritis, increase in the number of surgical procedures and increased healthcare expenditure.
The pain management market is categorized into non-steroidal anti-inflammatory drugs (NSAIDs), anesthetics, anticonvulsants, anti-migraine agents, anti-depressants, opioids, and non-narcotic analgesics. The pain management segment is further divided into arthritic pain, neuropathic pain, cancer pain, chronic back pain, postoperative pain, migraine, and fibromyalgia, bone fracture, muscle sprain, acute appendicitis, and other indications.